Non-serious adverse events
|
QD 0.5 mg |
QD 1 mg |
QD 2 mg |
QD 4 mg |
QD 8 mg |
QD 16 mg |
QD 25 mg |
QD 40 mg |
Dose Expansion cohort - HNSCC |
BID 15 mg |
BID 10 mg |
Dose Expansion cohort - GBM |
Dose Expansion cohort - ES |
Dose Expansion cohort - CRPC |
Dose Expansion cohort - CLL/SLL |
Dose Expansion cohort - BA/Food Effect |
Total subjects affected by non serious adverse events
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
1 / 1 (100.00%) |
1 / 1 (100.00%) |
1 / 1 (100.00%) |
3 / 4 (75.00%) |
6 / 6 (100.00%) |
6 / 6 (100.00%) |
7 / 7 (100.00%) |
6 / 6 (100.00%) |
18 / 18 (100.00%) |
6 / 6 (100.00%) |
6 / 6 (100.00%) |
14 / 14 (100.00%) |
10 / 10 (100.00%) |
12 / 12 (100.00%) |
8 / 8 (100.00%) |
12 / 12 (100.00%) |
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cancer pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Melanocytic naevus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Tumour haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Tumour necrosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Tumour pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Vascular disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arterial disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Deep vein thrombosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
Flushing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
Haematoma
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Hot flush
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Hypertension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Hypotension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
Orthostatic hypotension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Pallor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Peripheral coldness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
General disorders and administration site conditions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asthenia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
3 / 18 (16.67%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
4 / 10 (40.00%) |
3 / 12 (25.00%) |
2 / 8 (25.00%) |
4 / 12 (33.33%) |
occurrences all number
|
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
9 |
0 |
1 |
2 |
8 |
4 |
2 |
7 |
Chest discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Chills
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
3 |
0 |
0 |
0 |
2 |
0 |
0 |
2 |
0 |
2 |
1 |
0 |
0 |
0 |
0 |
Cyst
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Early satiety
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Face oedema
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
Facial pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
Fatigue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
1 / 6 (16.67%) |
2 / 6 (33.33%) |
6 / 7 (85.71%) |
5 / 6 (83.33%) |
11 / 18 (61.11%) |
4 / 6 (66.67%) |
3 / 6 (50.00%) |
10 / 14 (71.43%) |
4 / 10 (40.00%) |
10 / 12 (83.33%) |
1 / 8 (12.50%) |
7 / 12 (58.33%) |
occurrences all number
|
0 |
5 |
0 |
2 |
1 |
3 |
9 |
9 |
18 |
5 |
3 |
12 |
3 |
16 |
1 |
10 |
Gait disturbance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
1 |
General physical health deterioration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Influenza like illness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Malaise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mucosal inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
2 / 6 (33.33%) |
3 / 18 (16.67%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
2 / 8 (25.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
6 |
1 |
0 |
0 |
0 |
1 |
3 |
1 |
Non-cardiac chest pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
2 |
Oedema peripheral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
5 / 12 (41.67%) |
2 / 8 (25.00%) |
2 / 12 (16.67%) |
occurrences all number
|
1 |
0 |
0 |
0 |
1 |
1 |
2 |
1 |
4 |
0 |
3 |
1 |
0 |
4 |
2 |
2 |
Pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
Peripheral swelling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
Pyrexia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
5 / 18 (27.78%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
1 / 10 (10.00%) |
2 / 12 (16.67%) |
5 / 8 (62.50%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
6 |
0 |
1 |
1 |
1 |
1 |
0 |
5 |
0 |
5 |
2 |
1 |
2 |
9 |
2 |
Swelling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Temperature intolerance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Tenderness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Social circumstances
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HEARING IMPAIRMENT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Reproductive system and breast disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cervical polyp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Gynaecomastia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Pelvic pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Penile pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Vaginal discharge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Vaginal haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
Vulvovaginal swelling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Respiratory, thoracic and mediastinal disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DYSPNEA ON EXERTION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Atelectasis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Bronchial obstruction
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Bronchospasm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Catarrh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Chronic obstructive pulmonary disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Cough
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 1 (100.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
2 / 6 (33.33%) |
2 / 6 (33.33%) |
0 / 14 (0.00%) |
3 / 10 (30.00%) |
1 / 12 (8.33%) |
3 / 8 (37.50%) |
4 / 12 (33.33%) |
occurrences all number
|
0 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
2 |
3 |
2 |
0 |
4 |
1 |
3 |
3 |
Dysphonia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Dyspnoea
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
2 / 4 (50.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
3 / 6 (50.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
4 / 10 (40.00%) |
3 / 12 (25.00%) |
2 / 8 (25.00%) |
5 / 12 (41.67%) |
occurrences all number
|
0 |
2 |
0 |
2 |
0 |
2 |
0 |
0 |
6 |
6 |
1 |
0 |
6 |
3 |
2 |
6 |
Dyspnoea at rest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dyspnoea exertional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
2 |
Epistaxis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 7 (28.57%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
2 / 8 (25.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
Haemoptysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
Hiccups
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Hypoxia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Increased bronchial secretion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Lung infiltration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Nasal congestion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
1 |
0 |
Nasal inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Oropharyngeal pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
Paranasal sinus discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Pharyngeal inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Pleuritic pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
Pneumothorax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Productive cough
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
3 / 6 (50.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
Pulmonary embolism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Pulmonary oedema
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Respiratory tract congestion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Rhinorrhoea
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
3 / 8 (37.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
0 |
Sputum discoloured
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
0 |
Wheezing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Psychiatric disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abulia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Agitation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Anxiety
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
1 |
0 |
0 |
2 |
Bradyphrenia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Confusional state
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
2 / 6 (33.33%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
3 / 14 (21.43%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
2 |
3 |
0 |
0 |
0 |
1 |
Depression
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
3 |
Insomnia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
1 |
0 |
0 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
3 |
1 |
1 |
0 |
1 |
Irritability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Nervousness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Personality change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Restlessness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Sleep disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
2 / 8 (25.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
0 |
Investigations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Activated partial thromboplastin time prolonged
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Alanine aminotransferase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
2 / 6 (33.33%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
1 / 10 (10.00%) |
3 / 12 (25.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
1 |
2 |
1 |
3 |
1 |
1 |
Amylase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
1 |
0 |
1 |
Aspartate aminotransferase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
2 / 6 (33.33%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
2 / 10 (20.00%) |
4 / 12 (33.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
2 |
0 |
1 |
4 |
5 |
0 |
2 |
Bacterial test positive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Blood albumin decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Blood alkaline phosphatase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
2 / 6 (33.33%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
1 |
2 |
0 |
0 |
Blood bilirubin increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Blood cholesterol increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Blood creatine phosphokinase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
Blood creatinine increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
2 / 6 (33.33%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
1 |
7 |
0 |
0 |
0 |
0 |
1 |
3 |
Blood insulin increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Blood lactate dehydrogenase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
Blood phosphorus increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Blood thyroid stimulating hormone decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Blood thyroid stimulating hormone increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Blood triglycerides increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Breath sounds abnormal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
CD4 lymphocytes increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ejection fraction decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Eosinophil count increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
Gamma-glutamyltransferase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
0 |
Glucose urine present
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Glycosylated haemoglobin increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
0 |
1 |
Insulin C-peptide increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
1 / 6 (16.67%) |
3 / 6 (50.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
1 |
1 |
4 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
International normalised ratio increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Lipase increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
3 |
0 |
1 |
Lymphocyte count decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
0 |
0 |
Neutrophil count decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Platelet count decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Tandem gait test abnormal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Thyroxine increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Transaminases increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
Weight decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
7 / 18 (38.89%) |
3 / 6 (50.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
2 / 10 (20.00%) |
3 / 12 (25.00%) |
4 / 8 (50.00%) |
5 / 12 (41.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
3 |
1 |
1 |
9 |
4 |
1 |
1 |
2 |
5 |
6 |
7 |
Weight increased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
White blood cell count decreased
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
Injury, poisoning and procedural complications
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arthropod bite
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
Contusion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Ear injury
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Fall
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
Foreign body in eye
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Head injury
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Inappropriate schedule of product administration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Injury corneal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Muscle strain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Overdose
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
Post procedural discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Procedural pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
Skin laceration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
Skin wound
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Congenital, familial and genetic disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Primary immunodeficiency syndrome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Cardiac disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Angina pectoris
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Cardiomyopathy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Palpitations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Supraventricular tachycardia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Tachycardia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
MITRAL VALVE DISEASE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Nervous system disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aphasia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Apraxia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ataxia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
Disturbance in attention
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Dizziness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
2 |
0 |
1 |
0 |
0 |
1 |
1 |
2 |
0 |
1 |
2 |
0 |
2 |
1 |
4 |
Dysaesthesia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Dysarthria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dysgeusia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
2 |
0 |
2 |
1 |
1 |
Facial neuralgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
Facial paralysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Formication
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Headache
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
2 / 10 (20.00%) |
2 / 12 (16.67%) |
2 / 8 (25.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
1 |
4 |
2 |
2 |
2 |
2 |
2 |
Hemiparesis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Hyperaesthesia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Hypersomnia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Hypoaesthesia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
1 |
1 |
0 |
1 |
0 |
0 |
Lethargy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Memory impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
1 |
0 |
Neuralgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Neuropathy peripheral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Neurotoxicity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Paraesthesia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
3 |
Seizure
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
Sensory disturbance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Sensory loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Somnolence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
3 / 10 (30.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
0 |
0 |
1 |
Syncope
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
Taste disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Tremor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Trigeminal nerve paresis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Vocal cord paralysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Blood and lymphatic system disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
5 / 18 (27.78%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
5 / 10 (50.00%) |
1 / 12 (8.33%) |
2 / 8 (25.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
3 |
0 |
1 |
0 |
0 |
9 |
0 |
0 |
1 |
2 |
4 |
3 |
7 |
Eosinophilia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Iron deficiency anaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
Leukocytosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
Lymphopenia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Neutropenia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
3 / 8 (37.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
Normocytic anaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Thrombocytopenia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
2 / 12 (16.67%) |
3 / 8 (37.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
0 |
Ear and labyrinth disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deafness bilateral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ear discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Ear pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
Eustachian tube disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Hypoacusis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Tinnitus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Vertigo positional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Eye disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Blepharitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Blindness unilateral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Cataract
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Chorioretinal disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Diplopia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Dry eye
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Eye disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Eye pruritus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
Eyelid ptosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
1 |
Scleral hyperaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Strabismus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Vision blurred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
Visual impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
0 |
0 |
0 |
2 |
Gastrointestinal disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abdominal discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
Abdominal distension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Abdominal pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
2 / 7 (28.57%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
1 / 6 (16.67%) |
2 / 6 (33.33%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
4 / 12 (33.33%) |
occurrences all number
|
0 |
0 |
0 |
1 |
0 |
3 |
2 |
0 |
2 |
1 |
3 |
1 |
0 |
0 |
0 |
4 |
Abdominal pain lower
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Abdominal pain upper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
2 / 6 (33.33%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
Abdominal tenderness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Anal incontinence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Anal inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Anorectal discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Aphthous ulcer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
Breath odour
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Colitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Constipation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
2 / 6 (33.33%) |
2 / 6 (33.33%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
3 / 18 (16.67%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
3 / 10 (30.00%) |
3 / 12 (25.00%) |
1 / 8 (12.50%) |
4 / 12 (33.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
2 |
2 |
2 |
1 |
3 |
0 |
0 |
2 |
6 |
2 |
1 |
5 |
Dental caries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Diarrhoea
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
2 / 6 (33.33%) |
0 / 6 (0.00%) |
2 / 7 (28.57%) |
0 / 6 (0.00%) |
4 / 18 (22.22%) |
3 / 6 (50.00%) |
3 / 6 (50.00%) |
5 / 14 (35.71%) |
4 / 10 (40.00%) |
3 / 12 (25.00%) |
4 / 8 (50.00%) |
7 / 12 (58.33%) |
occurrences all number
|
0 |
1 |
0 |
0 |
2 |
0 |
4 |
0 |
5 |
6 |
10 |
9 |
8 |
5 |
7 |
13 |
Dry mouth
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
3 / 10 (30.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
1 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
2 |
3 |
2 |
0 |
2 |
Dyspepsia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
3 / 7 (42.86%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
1 |
0 |
0 |
4 |
2 |
1 |
Dysphagia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
2 / 6 (33.33%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Flatulence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
Frequent bowel movements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Gastrooesophageal reflux disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
Gingival bleeding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Glossodynia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
Haemorrhoids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
Nausea
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
4 / 6 (66.67%) |
3 / 6 (50.00%) |
4 / 7 (57.14%) |
4 / 6 (66.67%) |
7 / 18 (38.89%) |
2 / 6 (33.33%) |
3 / 6 (50.00%) |
4 / 14 (28.57%) |
5 / 10 (50.00%) |
4 / 12 (33.33%) |
3 / 8 (37.50%) |
10 / 12 (83.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
5 |
4 |
7 |
9 |
7 |
2 |
5 |
4 |
6 |
7 |
3 |
10 |
Odynophagia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
Oral pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
Rectal discharge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Rectal haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Stomatitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
3 / 7 (42.86%) |
3 / 6 (50.00%) |
1 / 18 (5.56%) |
2 / 6 (33.33%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
2 / 10 (20.00%) |
4 / 12 (33.33%) |
1 / 8 (12.50%) |
4 / 12 (33.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
8 |
5 |
2 |
5 |
2 |
3 |
3 |
5 |
1 |
9 |
Toothache
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
Vomiting
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
2 / 4 (50.00%) |
2 / 6 (33.33%) |
2 / 6 (33.33%) |
5 / 7 (71.43%) |
6 / 6 (100.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
4 / 6 (66.67%) |
2 / 14 (14.29%) |
3 / 10 (30.00%) |
3 / 12 (25.00%) |
0 / 8 (0.00%) |
6 / 12 (50.00%) |
occurrences all number
|
0 |
0 |
0 |
3 |
4 |
4 |
9 |
9 |
1 |
0 |
9 |
2 |
3 |
4 |
0 |
10 |
Hepatobiliary disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bile duct stenosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Biliary dilatation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Hyperbilirubinaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Jaundice
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Jaundice cholestatic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Skin and subcutaneous tissue disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRURITIC LESIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Acne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Alopecia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
Blister
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dermal cyst
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Dermatitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Dermatitis acneiform
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
3 / 14 (21.43%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
7 |
6 |
0 |
1 |
1 |
Dry skin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
1 |
2 |
0 |
3 |
Eczema
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Erythema
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
0 |
0 |
0 |
2 |
0 |
Erythema nodosum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Hyperhidrosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
Ingrowing nail
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
Intertrigo
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Nail disorder
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Night sweats
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
2 / 8 (25.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
Nodular rash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Onychalgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
Onychoclasis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
Pain of skin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Palmar-plantar erythrodysaesthesia syndrome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
Photosensitivity reaction
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Pruritus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
3 / 12 (25.00%) |
1 / 8 (12.50%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
2 |
0 |
2 |
3 |
1 |
5 |
Pruritus generalised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
Psoriasis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Purpura
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
Rash
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
4 / 7 (57.14%) |
2 / 6 (33.33%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
1 / 10 (10.00%) |
4 / 12 (33.33%) |
3 / 8 (37.50%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
8 |
2 |
2 |
0 |
2 |
2 |
1 |
11 |
4 |
5 |
Rash erythematous
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Rash generalised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Rash macular
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Rash maculo-papular
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 7 (14.29%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
2 / 6 (33.33%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
3 / 10 (30.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
2 |
0 |
0 |
0 |
1 |
4 |
1 |
7 |
7 |
3 |
2 |
5 |
2 |
0 |
2 |
Rash papular
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
Rash pruritic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9 |
2 |
1 |
0 |
1 |
0 |
0 |
Scab
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Skin discolouration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Skin fissures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
Skin irritation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Skin lesion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
Skin mass
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Skin ulcer haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Toxic skin eruption
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
Urticaria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
Renal and urinary disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chronic kidney disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
Dysuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
1 |
0 |
0 |
1 |
Glycosuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Haematuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
Incontinence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Leukocyturia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Nocturia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
Pollakiuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
3 / 12 (25.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
5 |
0 |
0 |
Proteinuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
2 / 8 (25.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
3 |
1 |
4 |
0 |
Renal atrophy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Renal vein thrombosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Urinary hesitation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Urinary incontinence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
Urinary retention
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Endocrine disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hypothyroidism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
3 / 6 (50.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
0 |
Musculoskeletal and connective tissue disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arthralgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 7 (28.57%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
3 / 12 (25.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
1 |
0 |
1 |
0 |
0 |
5 |
0 |
1 |
0 |
0 |
0 |
0 |
7 |
1 |
1 |
Back pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
3 / 12 (25.00%) |
0 / 8 (0.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
0 |
6 |
0 |
3 |
Bone pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Coccydynia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Flank pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
Groin pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Intervertebral disc protrusion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Joint stiffness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Joint swelling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Muscle spasms
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
2 / 6 (33.33%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
2 / 8 (25.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
3 |
1 |
0 |
1 |
0 |
0 |
1 |
3 |
0 |
0 |
2 |
5 |
2 |
Muscle twitching
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Muscular weakness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Musculoskeletal chest pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
Musculoskeletal discomfort
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Musculoskeletal pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
Musculoskeletal stiffness
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Myalgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
1 |
0 |
3 |
0 |
0 |
0 |
Neck pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Pain in extremity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
2 / 14 (14.29%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
0 |
0 |
1 |
2 |
3 |
0 |
0 |
1 |
Pain in jaw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Spondylitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Temporomandibular joint syndrome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Trismus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Infections and infestations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bacteraemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Bronchitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
Cellulitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Conjunctivitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Cystitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Eye infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Folliculitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
Fungal skin infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Gastroenteritis viral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
Herpes zoster
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
1 / 6 (16.67%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
2 / 8 (25.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
0 |
0 |
0 |
2 |
2 |
Kidney infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Laryngitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Lung infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Mastoiditis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Nasal vestibulitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Nasopharyngitis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
2 / 8 (25.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
Onychomycosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
Oral candidiasis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Oral herpes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
2 / 8 (25.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
0 |
Otitis externa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Otitis media
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Paronychia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
Pneumonia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
Postoperative wound infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Rash pustular
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Respiratory tract infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
Sepsis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Skin infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
Staphylococcal infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Tooth abscess
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Tooth infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Upper respiratory tract infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Urinary tract infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
2 / 8 (25.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
3 |
0 |
0 |
1 |
0 |
1 |
4 |
2 |
Urinary tract infection bacterial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
Viral infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
Wound infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Metabolism and nutrition disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cachexia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Decreased appetite
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
2 / 6 (33.33%) |
1 / 6 (16.67%) |
5 / 7 (71.43%) |
4 / 6 (66.67%) |
8 / 18 (44.44%) |
2 / 6 (33.33%) |
2 / 6 (33.33%) |
2 / 14 (14.29%) |
5 / 10 (50.00%) |
8 / 12 (66.67%) |
2 / 8 (25.00%) |
8 / 12 (66.67%) |
occurrences all number
|
0 |
1 |
0 |
0 |
2 |
2 |
5 |
3 |
9 |
2 |
2 |
3 |
7 |
10 |
2 |
8 |
Dehydration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
1 / 1 (100.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
1 / 6 (16.67%) |
2 / 18 (11.11%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
2 / 12 (16.67%) |
0 / 8 (0.00%) |
4 / 12 (33.33%) |
occurrences all number
|
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
2 |
1 |
0 |
0 |
0 |
3 |
0 |
5 |
Failure to thrive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
Hypercholesterolaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
8 |
0 |
0 |
0 |
0 |
0 |
0 |
Hyperglycaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
1 / 1 (100.00%) |
0 / 1 (0.00%) |
1 / 4 (25.00%) |
0 / 6 (0.00%) |
3 / 6 (50.00%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
4 / 18 (22.22%) |
2 / 6 (33.33%) |
1 / 6 (16.67%) |
6 / 14 (42.86%) |
3 / 10 (30.00%) |
4 / 12 (33.33%) |
1 / 8 (12.50%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
1 |
0 |
2 |
0 |
3 |
2 |
1 |
4 |
9 |
1 |
19 |
4 |
8 |
7 |
4 |
Hyperkalaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Hypertriglyceridaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
3 / 6 (50.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
2 |
21 |
0 |
0 |
2 |
0 |
0 |
0 |
Hyperuricaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
1 / 18 (5.56%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Hypervolaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Hypoalbuminaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
1 / 6 (16.67%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
2 / 10 (20.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
2 |
Hypocalcaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 7 (14.29%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
1 / 14 (7.14%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
Hypoglycaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
Hypokalaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
Hypomagnesaemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
2 / 18 (11.11%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
3 / 12 (25.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
Hyponatraemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
2 / 6 (33.33%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
4 / 18 (22.22%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
1 / 10 (10.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
2 / 12 (16.67%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
3 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
Hypophosphataemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
2 / 7 (28.57%) |
1 / 6 (16.67%) |
1 / 18 (5.56%) |
1 / 6 (16.67%) |
0 / 6 (0.00%) |
2 / 14 (14.29%) |
1 / 10 (10.00%) |
1 / 12 (8.33%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
1 |
0 |
5 |
3 |
1 |
0 |
1 |
Increased appetite
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
1 / 8 (12.50%) |
0 / 12 (0.00%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Vitamin D deficiency
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subjects affected / exposed
|
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 1 (0.00%) |
0 / 4 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 7 (0.00%) |
0 / 6 (0.00%) |
0 / 18 (0.00%) |
0 / 6 (0.00%) |
0 / 6 (0.00%) |
0 / 14 (0.00%) |
0 / 10 (0.00%) |
0 / 12 (0.00%) |
0 / 8 (0.00%) |
1 / 12 (8.33%) |
occurrences all number
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |